These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19500588)

  • 1. Ligand binding and substrate discrimination by UDP-galactopyranose mutase.
    Gruber TD; Borrok MJ; Westler WM; Forest KT; Kiessling LL
    J Mol Biol; 2009 Aug; 391(2):327-40. PubMed ID: 19500588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
    Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
    J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
    Partha SK; van Straaten KE; Sanders DA
    J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray crystallography reveals a reduced substrate complex of UDP-galactopyranose mutase poised for covalent catalysis by flavin.
    Gruber TD; Westler WM; Kiessling LL; Forest KT
    Biochemistry; 2009 Oct; 48(39):9171-3. PubMed ID: 19719175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of ligand binding to UDP-galactopyranose mutase from Mycobacterium tuberculosis using substrate and tetrafluorinated substrate analogues.
    van Straaten KE; Kuttiyatveetil JR; Sevrain CM; Villaume SA; Jiménez-Barbero J; Linclau B; Vincent SP; Sanders DA
    J Am Chem Soc; 2015 Jan; 137(3):1230-44. PubMed ID: 25562380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of binding of UDP-Galf and UDP-[3-F]Galf to UDP-galactopyranose mutase by STD-NMR spectroscopy, molecular dynamics, and CORCEMA-ST calculations.
    Yuan Y; Bleile DW; Wen X; Sanders DA; Itoh K; Liu HW; Pinto BM
    J Am Chem Soc; 2008 Mar; 130(10):3157-68. PubMed ID: 18278916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of UDP-galactopyranose mutase reveals a critical role for the active-site, conserved arginine residues.
    Chad JM; Sarathy KP; Gruber TD; Addala E; Kiessling LL; Sanders DA
    Biochemistry; 2007 Jun; 46(23):6723-32. PubMed ID: 17511471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insight into the unique substrate binding mechanism and flavin redox state of UDP-galactopyranose mutase from Aspergillus fumigatus.
    van Straaten KE; Routier FH; Sanders DA
    J Biol Chem; 2012 Mar; 287(14):10780-90. PubMed ID: 22334662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-galactopyranose mutase in nematodes.
    Wesener DA; May JF; Huffman EM; Kiessling LL
    Biochemistry; 2013 Jun; 52(25):4391-8. PubMed ID: 23697711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique catalytic mechanism for UDP-galactopyranose mutase.
    Soltero-Higgin M; Carlson EE; Gruber TD; Kiessling LL
    Nat Struct Mol Biol; 2004 Jun; 11(6):539-43. PubMed ID: 15133501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Control of UDP-Galactopyranose Mutase Inhibition.
    Wangkanont K; Winton VJ; Forest KT; Kiessling LL
    Biochemistry; 2017 Aug; 56(30):3983-3992. PubMed ID: 28608671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the mechanism of binding of UDP-galactopyranose to UDP-galactopyranose mutase by STD-NMR spectroscopy and molecular modeling.
    Yuan Y; Wen X; Sanders DA; Pinto BM
    Biochemistry; 2005 Nov; 44(43):14080-9. PubMed ID: 16245924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate directs enzyme dynamics by bridging distal sites: UDP-galactopyranose mutase.
    Yao X; Bleile DW; Yuan Y; Chao J; Sarathy KP; Sanders DA; Pinto BM; O'Neill MA
    Proteins; 2009 Mar; 74(4):972-9. PubMed ID: 18767162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical probes of UDP-galactopyranose mutase.
    Carlson EE; May JF; Kiessling LL
    Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state.
    Beis K; Srikannathasan V; Liu H; Fullerton SW; Bamford VA; Sanders DA; Whitfield C; McNeil MR; Naismith JH
    J Mol Biol; 2005 May; 348(4):971-82. PubMed ID: 15843027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
    Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
    Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tautomerization in the UDP-galactopyranose mutase mechanism: a DFT-cluster and QM/MM investigation.
    Huang W; Gauld JW
    J Phys Chem B; 2012 Dec; 116(48):14040-50. PubMed ID: 23148701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-4-Keto-6-Deoxyglucose, a Transient Antifungal Metabolite, Weakens the Fungal Cell Wall Partly by Inhibition of UDP-Galactopyranose Mutase.
    Ma L; Salas O; Bowler K; Bar-Peled M; Sharon A
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach.
    Nayak T; Jena L; Waghmare P; Harinath BC
    Int J Mycobacteriol; 2018; 7(1):61-68. PubMed ID: 29516888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.
    Dykhuizen EC; Kiessling LL
    Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.